Barclays’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Buy |
101,878
+31,878
| +46% | +$86.4K | ﹤0.01% | 3347 |
|
|
2025
Q1 | $237K | Hold |
70,000
| – | – | ﹤0.01% | 3239 |
|
|
2024
Q4 | $288K | Buy |
+70,000
| New | +$288K | ﹤0.01% | 3348 |
|
|
2019
Q2 | – | Sell |
-4
| Closed | – | – | 4271 |
|
|
2019
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 4287 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4165 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4341 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 4232 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4240 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4097 |
|
|
2017
Q3 | – | Sell |
-3
| Closed | – | – | 4035 |
|
|
2017
Q2 | $0 | Sell |
3
-73
| -96% | – | ﹤0.01% | 3913 |
|
|
2017
Q1 | $10K | Buy |
76
+51
| +204% | +$6.71K | ﹤0.01% | 3527 |
|
|
2016
Q4 | $4K | Buy |
25
+19
| +317% | +$3.04K | ﹤0.01% | 3469 |
|
|
2016
Q3 | $1K | Buy |
6
+4
| +200% | +$667 | ﹤0.01% | 3729 |
|
|
2016
Q2 | $2K | Buy |
2
+1
| +100% | +$1K | ﹤0.01% | 3273 |
|
|
2016
Q1 | $1K | Sell |
1
-2
| -67% | -$2K | ﹤0.01% | 3287 |
|
|
2015
Q4 | $4K | Buy |
+3
| New | +$4K | ﹤0.01% | 2937 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$2K | – | 3989 |
|
|
2015
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 3901 |
|
|
2015
Q1 | $2K | Sell |
1
-2
| -67% | -$4K | ﹤0.01% | 3899 |
|
|
2014
Q4 | $7K | Buy |
+3
| New | +$7K | ﹤0.01% | 3862 |
|